CYP3A5, which is downregulated in hepatocellular carcinomas, has been found to suppress HCC pathogenesis by inducing ROS accumulation and subsequent inhibition of mTORC2/Akt signaling [51]. Here, AKT1 is linked to hepatocellular carcinoma.